Abstract
The rapid growth of the Internet parallels advances in the treatment of primary HIV infection. Recent breakthroughs in the use of viral load testing have shifted the focus away from monotherapy to highly active antiretroviral therapy (HAART) with combination regimens. Currently, three classes of drugs are available for the treatment of primary HIV infection and include the nucleoside and non-nucleoside reverse transcriptase inhibitors and the protease inhibitors. A review of the historical development of these compounds and some Internet resources is presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
